Eric Duverger

In vivo gene delivery in the mouse lung with lactosylated polyethylenimine, questioning the relevance of in vitro experiments.

Polyethylenimine (PEI) is an efficient vector for in vitro and in vivo gene transfer into respiratory cells. Glycosylated PEIs were shown to enhance in vitro gene transfer by favoring the complex entry into the airway cells. The aim of our study was to evaluate the in vivo efficiency of gene transfer mediated by glycosylated PEIs in the mouse lung and to determine the transfected cell type and the intracellular trafficking of the complexes. Upon nasal instillation in mice of complexes made with various glycosylated PEIs, a high luciferase activity was observed while the green fluorescent protein (GFP) expression was similar for all the vectors tested with few cells expressing GFP. Complexes made with lactosylated PEI were then labeled and their localization studied by confocal microscopy. In the lungs, large numbers of complexes were taken up by epithelial cell which were mostly alveolar cells. In the airways, complex uptake varied greatly, depending on the area observed. Eight hours upon nasal instillation and in contrast with the in vitro situation, a dissociation between the plasmid DNA and the lactosylated PEI was usually observed, leading to the plasmid mostly localized in lysosomes and the Lac-PEI localized in the nucleus. These results emphasize the need to engineer a plasmid able by itself to overcome the nuclear barrier and to quickly move to in vivo experiments to select the best carrier.

Cross-Presentation of Synthetic Long Peptides by Human Dendritic Cells: A Process Dependent on ERAD Component p97/VCP but Not sec61 and/or Derlin-1

Antitumor vaccination using synthetic long peptides (SLP) is an additional therapeutic strategy currently under development. It aims to activate tumor-specific CD8+ CTL by professional APCs such as DCs. DCs can activate T lymphocytes by MHC class I presentation of exogenous antigens - a process referred to as “cross-presentation”. Until recently, the intracellular mechanisms involved in cross-presentation of soluble antigens have been unclear. Here, we characterize the cross-presentation pathway of SLP Melan-A16–40 containing the HLA-A2-restricted epitope26–35 (A27L) in human DCs. Using confocal microscopy and specific inhibitors, we show that SLP16–40 is rapidly taken up by DC and follows a classical TAP- and proteasome-dependent cross-presentation pathway. Our data support a role for the ER-associated degradation machinery (ERAD)-related protein p97/VCP in the transport of SLP16–40 from early endosomes to the cytoplasm but formally exclude both sec61 and Derlin-1 as possible retro-translocation channels for cross-presentation. In addition, we show that generation of the Melan-A26–35 peptide from the SLP16–40 was absolutely not influenced by the proteasome subunit composition in DC. Altogether, our findings propose a model for cross-presentation of SLP which tends to enlarge the repertoire of potential candidates for retro-translocation of exogenous antigens to the cytosol.

Electrophoretically mediated microanalysis for in-capillaryelectrical cell lysis and fast enzyme quantification by capillary electrophoresis

AbstractIn this study, a novel capillary electrophoresis (CE)-based enzymatic assay was developed to evaluate enzymatic activity in whole cells. β-Galactosidase expression was used as an example, as it is a biomarker for assessing replicative senescence in mammalian cells. It catalyzes the hydrolysis of para-nitrophenyl-β-d-galactopyranoside (PNPG) into para-nitrophenol (PNP). The CE-based assay consisted of four main steps: (1) hydrodynamic injection of whole intact cells into the capillary, (2) in-capillary lysis of these cells by using pulses of electric field (electroporation), (3) in-capillary hydrolysis of PNPG by the β-galactosidase—released from the lysed cells—by the electrophoretically mediated microanalysis (EMMA) approach, and (4) on-line detection and quantification of the PNP formed. The developed method was applied to Escherichia coli as well as to human keratinocyte cells at different replicative stages. Results obtained by CE were in excellent agreement with those obtained from off-line cell lysates which proves the efficiency of the in-capillary approach developed. This work shows for the first time that cell membranes can be disrupted in-capillary by electroporation and that the released enzyme can be subsequently quantified in the same capillary. Enzyme quantification in cells after their in-capillary lysis has never been conducted by CE. The developed CE approach is automated, economic, eco-friendly, and simple to conduct. It has attractive applications in bacteria or human cells for early disease diagnostics or insights for development in biology.n FigureElectropherograms for in-capillary reaction catalyzed by β-galactosidase obtained from off-capillary and in-capillary lysis of E. coli cells.

Cell surface lectin array: parameters affecting cell glycan signature

Among the “omics”, glycomics is one of the most complex fields and needs complementary strategies of analysis to decipher the “glycan dictionary”. As an alternative method, which has developed since the beginning of the 21st century, lectin array technology could generate relevant information related to glycan motifs, accessibility and a number of other valuable insights from molecules (purified and non-purified) or cells. Based on a cell line model, this study deals with the key parameters that influence the whole cell surface glycan interaction with lectin arrays and the consequences on the interpretation and reliability of the results. The comparison between the adherent and suspension forms of Chinese Hamster Ovary (CHO) cells, showed respective glycan signatures, which could be inhibited specifically by neoglycoproteins. The modifications of the respective glycan signatures were also revealed according to the detachment modes and cell growth conditions. Finally the power of lectin array technology was highlighted by the possibility of selecting and characterizing a specific clone from the mother cell line, based on the slight difference determination in the respective glycan signatures.

Carbohydrate–Lectin Interactions Assayed by SPR

Surface plasmon resonance is a valuable tool to determine the affinity between glycoconjugates and sugar-binding proteins such as plant and animal lectins. The main interest of using such an approach is that neither the lectins - which are proteins - nor their ligands - natural compounds such as glycoproteins, oligosaccharides, polysaccharides, or synthetic glycoconjugates such as glycoclusters or neoglycoproteins - require any tag. Because lectins bear several binding sites, they behave like immunoglobulin eliciting avidity phenomena. This peculiarity may lead to erroneous results if special conditions are not applied. We obtained best and reproducible results when the lectin was immobilized and its ligands were used as soluble analytes. With heterogeneous glycoconjugates such as neoglycoproteins (which are heterogeneous in terms of nature, number, and position of sugar residues) or a mixture of oligosaccharides, the data may be more accurately gathered by using the Sips approach, which has been used to determine mean binding constants of polyclonal antibodies. With small analytes such as oligosaccharides, we found it convenient to determine binding constants by using an inhibitory approach: a neoglycoprotein (M (r) = approximately 80,000) was allowed to bind to the immobilized lectin and small oligosaccharides were used as inhibitors. With larger glycoconjugates such as peptides substituted with glycoclusters, direct binding measurements gave accurate results. Because of the availability of low-cost simple sugars (mono- or disaccharides) it is very convenient to use large concentrations of such carbohydrates to clean the sensor chips instead of more drastic cleaning solutions such as acids or alkali, in such a way that the immobilized lectin is stable for many experiments.

Interaction between lectins and neoglycoproteins containing new sialylated glycosynthons

Neoglycoconjugates are useful tools to study carbohydrate/protein interactions. In order to discover new lectins, to define their fine specificity or to study their intracellular trafficking, there is a need for neoglycoconjugates containing complex oligosaccharides. We recently set up a simple way to transform native oligosaccharides into glycosynthons. The present paper describes i[emsp4 ]) the synthesis of such glycosynthons starting with sialylated oligosides, ii[emsp4 ]) the preparation of sialylated neoglycoproteins and iii[emsp4 ]) their binding to sialic acid-specific lectins assessed by surface plasmon resonance experiments.

Purification of lectins from Robinia pseudoacacia L. root-tips

Abstract The presence of lectins in Robinia pseudoacacia root-tip extracts was demonstrated by horse erythrocyte agglutination and aggregation of (neo)glycoprotein-coated beads. Two lectins were purified from a crude protein extract by ion-exchange and affinity chromatography. A mixture of lectins was obtained by cation-exchange chromatography on a CM-Trisacryl column. Robinia pseudoacacia root agglutinin II (RPrAII) was further purified by specific elution from a GalNAc-BSA-Sepharose-4B column. Material passing through the GalNAc-BSA-Sepharose-4B column was still active as determined by erythrocyte agglutination, and aggregated orosomucoid-coated beads, this material was further purified by affinity chromatography on an orosomucoid-Sepharose-4B column. Elution with 50 mM HCl at pH 1.5 led to the purification of the second lectin referred as Robinia pseudoacacia root agglutinin I (RPrAI). Biochemical analysis suggests that RPrAI is a heterodimer made up of M r 29 000 and 31 000 subunits whereas RPrAII is a homodimer made up of M r 30 000 subunits, and that both lectins are glycoproteins. N-terminal sequences were determined for both lectins and compared with those deduced from cDNA clones encoding bark and seed lectins. Our results suggest that root lectins are not strictly identical with, but closely related to the Robinia pseudoacacia seed and bark lectins.

Lectin Glycoprofiling of Recombinant Therapeutic Interleukin-7

Lectins array is a powerfull and complementary method of glycans analysis allowing fast identification of specific motifs on molecules or cells. This technology is of increased interest for the development of therapeutic recombinant glycoproteins and particularly relevant for a first study of lot-to-lot comparison, or detection of unwanted glycans. In this chapter, we describe a lectin array-type method specifically designed for the study of recombinant therapeutic interleukin-7 (rhIL-7). This specific method allows the analysis of the glycans motifs, the distribution of the glycoforms population, and the detection of potential immunogen glycans in rhIL-7 purified CHO-produced batches.